Nichi-Iko Pharmaceutical Stock (OTC: NHKFF)

Latest news for Nichi-Iko Pharmaceutical (OTC:NHKFF) Stock

Nichi-Iko Pharmaceutical Co Ltd is a major drug manufacturing company in Japan. Its core business includes the manufacture and sale of generic pharmaceutical products, through sales to pharmaceutical wholesalers and medical institutions. The vast majority of the company's sales are derived from prescription drugs. The company operates various subsidiaries across an array of other countries, including Thailand.

News

Rumors

Movers

NHKFF

SGNT

Benzinga&#39;s M&amp;A Chatter for Monday July 11, 2016

NICHIIKO PHARM CO LTD ORD by Nichiiko Pharmaceutical Co., Ltd.

Nichi-Iko Pharmaceutical Co Ltd

Nichi-Iko Pharmaceutical

The following are the M&amp;A deals, rumors and chatter circulating on Wall Street for Monday July 11, 2016:

	Nichi-Iko Pharmaceutical Co. to Acquire Sagent Pharmaceuticals for $21.75/Share in Cash

	The Deal: 
	Nichi-Iko Pharmaceutical Co., Ltd OTC: NHKFF) and Sagent Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="/stock/sgnt#NASDAQ">SGNT</a>) announced Monday, that they have entered into a definitive merger agreement under which Nichi-Iko will acquire Sagent via an all-cash tender offer for $21.75 per share, for a total consideration of approximately $736 million. The acquisition is not subject to any financing condition.

	Sagent Pharmaceuticals closed at $21.65 on Monday, up 39.68%.

	&nbsp;

	Concord Medical Announces Takeover Offer for $5.19/Share

	The Offer: 
	Concord Medical Services Holdings Limited (NYSE: <a class="ticker" href="/stock/ccm#NYSE">CCM</a>) announced Monday, that its board of directors has received a non-binding proposal letter, dated July 11, 2016, from Chairman and CEO Jianyu Yang, Morgancreek Investment Holdings Limited and Blue Ocean Management Limited to acquire all of the outstanding Class A ordinary shares and ADSs, each representing three Class A ordinary shares for $1.73 per Class A ordinary share or US$5.19 per ADS. The Board will carefully review the proposal from the buyer to determine the course of action that it believes is in the best interests of the company&#39;s shareholders.

	Concord Medical closed at $4.29 on Monday, up 10.48%.

	&nbsp;

	UFC Sold for $4B to Group Led by WME-IMG

	The Deal: 
	WME | IMG today announced the acquisition of mixed martial arts promoter Ultimate Fighting Championship or UFC. The purchase price is $ 4 billion.

	Shares of WWE moved higher in sympathy, closing Monday at $20.46, up 4.97%.

	&nbsp;

	Xerox in Talks to Merge Copy Business With RR Donnelley 

	The Rumor: 
	Xerox Corp XRX.N is said to be in talks to merge its copy business with RR Donnelley, according to a reported as tweeted by CNBC. Xerox closed Monday at $9.50, and traded at $9.80 after-hours.

Comments

Nichi-Iko Pharmaceutical

News

Latest news for Nichi-Iko Pharmaceutical (OTC:NHKFF) Stock

Monday, July 11, 2016

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga